Neutrophil extracellular traps drive osteoporosis via NCF2-dependent signaling: integrated transcriptomics with

Xiangyun Guo1,2, Liang Wang1, Shuangliu Chen3

  • 1School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.

Abstract

Insights

Neutrophil extracellular traps (NETs) contribute to osteoporosis (OP) by impairing osteoblast function. Targeting the NCF2 gene shows potential for novel OP therapies by reducing NETs formation and protecting bone metabolism.

Area of Science:

  • Osteoimmunology
  • Molecular Biology
  • Bone Metabolism

Background:

  • Inflammation and immune responses are critical in osteoporosis (OP) pathogenesis.
  • Osteoimmunology research indicates immune dysregulation contributes significantly to OP.
  • Specific mechanisms linking immune dysfunction to bone loss require elucidation for targeted therapies.

Purpose of the Study:

  • To investigate the role of neutrophil extracellular traps (NETs) in osteoporosis.
  • To identify key genes and pathways involved in immune-mediated bone loss.
  • To explore potential therapeutic targets for OP.

Main Methods:

  • Established a rat osteoporosis model using bilateral ovariectomy.
  • Utilized transcriptomic sequencing (RNA-seq) to identify differentially expressed genes (DEGs).
  • Performed summary data-based Mendelian randomization (SMR) analysis to validate gene-OP associations.
  • Investigated neutrophil extracellular trap (NET) formation and the role of the NCF2 gene in vitro.
  • Assessed the impact of NETs on osteoblast differentiation.

Main Results:

  • RNA-seq identified 4,497 DEGs in OP rats, enriched in immune response and NETs pathways.
  • NETs markers were elevated in OP bone tissue and stimulated neutrophils.
  • SMR analysis and experimental validation identified VDAC1, PLCG2, and NCF2 as key genes associated with OP risk.
  • NCF2 knockdown reduced NETs formation and mitigated NETs-induced impairment of osteoblast differentiation.
  • Drug prediction and molecular docking suggested pharmacological potential for targeting these genes.

Conclusions:

  • This study establishes a link between NETs formation and osteoporosis.
  • NCF2 is identified as a crucial gene in the NETs-osteoporosis axis.
  • Findings offer new insights into immune inflammation's role in bone metabolism and suggest novel therapeutic strategies for OP.